DFTX: Leerink Raises Target
Leerink Partners maintains Outperform on Definium Therapeutics and raises price target to $52
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.